←
Wafik S. El-Deiry, MD, PhD, FACP70,739 posts
Wafik S. El-Deiry, MD, PhD, FACP avatar✓

Wafik S. El-Deiry, MD, PhD, FACP ✓

@weldeiry

Physician-Scientist tinyurl.com/s98xg3u Discovered p21(WAF1), TRAIL DR5, TIC10/ONC201; 1st ever FDA approval for H3K27M-glioma IU Physician-MBA Class '28

◷ Joined April 2008▧ 7,673 Photos and videos
David J Harris Jr avatar
⟳ Wafik S. El-Deiry, MD, PhD, FACP retweeted
David J Harris Jr@DavidJHarrisJr·12h

🚨BREAKING: A California professor is pulling in nearly $800,000 a year by teaching 30 classes to 1,100 students across nine colleges at the same time. Thien-Huong Ninh Villarreal holds two full-time and seven part-time jobs teaching sociology, ethnic studies, and business, mostly with pre-recorded online lectures. A CalMatters investigation found more than 70 instructors are doing the same thing, working across at least five districts or campuses with no rules limiting how many places one person can teach. Another instructor, Andrew Vanden Heuvel, taught around 50 online astronomy classes from an office above his garage in Michigan and earned $758,485 in 2024. He said his quizzes are multiple choice and graded by computer, and he is not grading anything himself. There is no statewide tracking system. Each of California’s 73 community college districts operates independently, so no one is watching the actual workload. Students are paying for classes while professors collect multiple full salaries for pre-recorded content. This is the education system California built.

Post attachment
Jame Abraham, MD, FACP avatar
⟳ Wafik S. El-Deiry, MD, PhD, FACP retweeted
Jame Abraham, MD, FACP@jamecancerdoc·9h

25 years ago, as an @theNCI fellow, I started a handbook. Now The Bethesda Handbook of Clinical Oncology is in its 7th edition, translated worldwide. Grateful to co-editor Dr. JamesGulley hundreds of authors, and the clinicians who use it every day share.google/JPbRmW2MejOkKK3…

Post attachment
Wafik S. El-Deiry, MD, PhD, FACP avatar
Wafik S. El-Deiry, MD, PhD, FACP@weldeiry·6h

CCNE1 Amplification Confers Poor Outcomes and Therapeutic Resistance in Breast Cancer 
Clinical Cancer Research, online November 17, 2026 · Antonio Marra (European Institute of Oncology) … Sarat Chandarlapaty, Pedram Razavi and Ezra Y. Rosen (Memorial Sloan Kettering), with Britta Weigelt and Jorge Reis-Filho · Therapy resistance / new therapy targets AI summary reviewed and approved by Dr. El-Deiry: 
“CCNE1 amplification is established as a driver and a poor-prognosis marker in ovarian and gastric cancer; establishing its weight in breast cancer matters now rather than five years ago because of what is in development against it. Cyclin E1 overexpression drives CDK2-dependent proliferation that bypasses CDK4/6 inhibition, which is the dominant first-line backbone in ER-positive disease, and selective CDK2 inhibitors are in trials specifically for this dependency. If the amplification is both prognostic and predictive of resistance, it becomes a testable reason to sequence a CDK2 agent rather than cycling endocrine therapy. From the MSK group that has done much of the genomic work on endocrine resistance. Ahead-of-print and summarized from the record; whether the resistance is specific to CDK4/6 inhibition or reflects general aggressiveness is the distinction the full text needs to make.”
doi.org/10.1158/1078-0432.CC…

Wafik S. El-Deiry, MD, PhD, FACP avatar
Wafik S. El-Deiry, MD, PhD, FACP@weldeiry·7h

And a collaborative grant between @BrownUniversity and p53-Therapeutics is being submitted today by an amazing academic and industry team in this case focused on investigating a future novel therapy for triple negative breast cancer, an area of unmet medical need in oncology. We never know if our grants will be funded but we keep trying to research novel options for patients.

Post attachment
Wafik S. El-Deiry, MD, PhD, FACP avatar
Wafik S. El-Deiry, MD, PhD, FACP@weldeiry·7h

Attending my @KelleyBizMed Tuesday evening Business Analytics for Physicians K524 class from Shanghai where it is Wednesday morning. Learning about data analytic tools including data visualization to improve patient outcomes for best in-class healthcare, population health management, personalized care, and predictive modeling. Challenges and data governance included along with potential impact of AI.

Post attachmentPost attachmentPost attachmentPost attachment